07 Jan 2001

Psorcutan® Salbe (Psorcutan® Salbe) - Deutschland

Updated: 07 Jan 2001

Psorcutan® Salbe

Leichte bis mittelschwere Psoriasis vom Plaque Typ.

Psorcutan® Salbe Description, Presentation and Dosage

Psorcutan® Salbe Description

Psorcutan® Salbe Drug Class Description

Einzelstoffe

Psorcutan® Salbe Drug Description

1 g enth.: Calcipotriol 0,05 mg.

Psorcutan® Salbe Generic Name

Psorcutan® Salbe

Psorcutan® Salbe Presentation

Psorcutan® Salbe Presentation

Psorcutan® Salbe

Psorcutan® Salbe Manufacturer

Schering/Asche

Related Learning Zones

Cystic Fibrosis Knowledge Centre

Cystic Fibrosis Knowledge Centre

Cystic fibrosis (CF) is a genetic condition caused by a defect in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. The Cystic Fibrosis Knowledge Centre provides healthcare professionals with access to disease awareness information, emerging and established treatment options and current best practice based on recently updated guidelines by the European Cystic Fibrosis Society (ECFS). A resources section contains external links to upcoming medical conferences and patient support groups.

This resource is developed by EPG Health Media for epgonline.org, supported by an independent educational grant from Vertex.

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Psorcutan® Salbe Dosage

Psorcutan® Salbe Adult Dosage

Wasser-Öl-Emulsion, gereinigtes Wasser, Dinatriumedetat 2H2O, Natriummonohydrogenphosphat 2H2O, 'alpha'-Tocopherol, dickflüssiges Paraffin, 'alpha'-Octadecyl-'omega'-hydroxypoly(oxyethylen)-2, Propylenglycol, weißes Vaselin.

Psorcutan® Salbe Precautions, Reactions and Contraindications

Psorcutan® Salbe Special Precautions

Psorcutan® Salbe Special Precautions

Anw. auf größeren Hautflächen als max. 30% d. Körpers. Psoriasis punctata, Psoriasis pustulosa, schwere Nieren- o. Lebererkrank. b. allen Erkrank. die m. Veränd. d. Kalziumstoffwechsels einhergehen, i. Gesicht u. auf d. behaarten Kopf, b. Pers. unter 18 Jahren.

Psorcutan® Salbe Adverse Reactions

Psorcutan® Salbe Adverse Reactions

Kontraind. Gr 4 .

Related Drugs - Dermatology

Back to top